(Q44732056)

English

Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 December 2017

Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy (English)

1 reference

Europe PubMed Central

5 December 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Petit T

1

1 reference

Europe PubMed Central

5 December 2017

Wilt M

2

1 reference

Europe PubMed Central

5 December 2017

Velten M

3

1 reference

Europe PubMed Central

5 December 2017

Millon R

4

1 reference

Europe PubMed Central

5 December 2017

Rodier JF

5

1 reference

Europe PubMed Central

5 December 2017

Borel C

6

1 reference

Europe PubMed Central

5 December 2017

Mors R

7

1 reference

Europe PubMed Central

5 December 2017

Haegelé P

8

1 reference

Europe PubMed Central

5 December 2017

Eber M

9

1 reference

Europe PubMed Central

5 December 2017

Ghnassia JP

10

1 reference

Europe PubMed Central

5 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2004

1 reference

Europe PubMed Central

5 December 2017

European Journal of Cancer

1 reference

Europe PubMed Central

5 December 2017

40

1 reference

Europe PubMed Central

5 December 2017

2

1 reference

Europe PubMed Central

5 December 2017

205-211

1 reference

Europe PubMed Central

5 December 2017

Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer. the role of clinical response

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900675-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900675-0

7 January 2021

based on heuristic

inferred from DOI database lookup

HER2. a 'predictive factor' ready to use in the daily management of breast cancer patients?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900675-0

7 January 2021

based on heuristic

inferred from DOI database lookup

When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900675-0

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA topoisomerase poisons as antitumor drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900675-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900675-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900675-0

7 January 2021

based on heuristic

inferred from DOI database lookup

HER-2 and topo-isomerase IIalpha as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900675-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive value of tumour cell proliferation in locally advanced breast cancer treated with neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900675-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900675-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological markers as indicators of response to primary and adjuvant chemotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900675-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cell cycle modifications of breast cancers during neoadjuvant chemotherapy: a flow cytometry study on fine needle aspirates

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900675-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of response to primary chemotherapy for operable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900675-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Strong correlation between results of fluorescent in situ hybridization and immunohistochemistry for the assessment of the ERBB2 (HER-2/neu) gene status in breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900675-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900675-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of HER2/neu status assessed by quantitative polymerase chain reaction and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900675-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Human DNA topoisomerase II-alpha: a new marker of cell proliferation in invasive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900675-0

7 January 2021

based on heuristic

inferred from DOI database lookup

erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900675-0

7 January 2021

based on heuristic

inferred from DOI database lookup

erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900675-0

7 January 2021

based on heuristic

inferred from DOI database lookup

c-erbB-2 (HER-2/neu) protein and drug resistance in breast cancer patients treated with induction chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900675-0

7 January 2021

based on heuristic

inferred from DOI database lookup

ERBB2 overexpression in breast carcinomas: no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900675-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation between HER-2 expression and response to neoadjuvant chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide in patients with breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900675-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900675-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Topoisomerase II-alpha (topoII) and HER2 amplification in breast cancers and response to preoperative doxorubicin chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900675-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression profiling predicts clinical outcome of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900675-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(03)00675-0

1 reference

Europe PubMed Central

5 December 2017

1 reference

Europe PubMed Central

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44732056&oldid=2035551513"